PlexPCR^® Flu/RSV/SARS-CoV-2

Upfront Diagnosis

This Class B IVDR Certified and TGA-cleared product detects clinically relevant seasonal respiratory viruses Influenza A, Influenza B, Respiratory Syncytial Virus (A&B) and SARS-CoV-2 virus in a single-well multiplex qPCR test.

Triage seasonal respiratory testing with PlexPCR® Flu/RSV/SARS-CoV-2

Infections caused by Flu A, Flu B, RSV (A & B), and SARS-CoV-2 can all present with similar clinical symptoms. Adopt PlexPCR® Flu/RSV/SARS-CoV-2 to triage and diagnose these important seasonal respiratory viruses upfront.

• Class B IVDR Certified and TGA-cleared

• Stay ahead of seasonal influenza that results in substantial worldwide disease burden¹

• RSV is an important inclusion. It is a common cause of respiratory infections, and the main cause of severe cases of bronchiolitis and pneumonia in infants and young children^2,3

• Confidently detect SARS-CoV-2, including current known circulating variants⁴

With peaks in seasonal respiratory test numbers, sample workload for laboratories can push testing capacity. Prioritising detection of common respiratory viruses with a uniform testing approach can improve efficiency and productivity.

PlexPCR® Flu/RSV/SARS-CoV-2 Workflow Solution — Combat seasonal testing surges with ease

Take advantage of our flexible workflow to achieve scalable throughput, easily adapting to seasonal test surges.

• Maximise detection with this single-well multiplex test, by simultaneously detecting Flu A, Flu B, RSV (A & B), and SARS-CoV-2.

• Obtain high sample throughput. Process up to 96 reactions per run and maintain clinically relevant turn-around times during peak testing season.

• Utilise provided analysis software to achieve automated result calling and simple data processing.    

  
  

Affordable and Efficient

The COVID-19 pandemic and recent respiratory testing seasons have impacted laboratories with dramatic fluctuations in testing demands and staffing. Some laboratories are left with underused equipment and a drive to replace lost revenue, highlighting the need for affordable and efficient solutions.

PlexPCR^® Flu/RSV/SARS-CoV-2 can help your laboratory work effectively and efficiently.

• Upfront diagnosis, with a focussed multiplex and robust workflow, will streamline your routine testing

• Test with your existing QuantStudio 5 instrument and avoid the expense of acquiring new systems and associated training, implementation and service contract costs.

PlexPCR® Flu/RSV/SARS-CoV-2 Performance Specifications

Demonstrated clinical performance – for more detail please see the PlexPCR^® Flu/RSV/SARS-CoV-2 Instructions for Use.